Jim Cramer on Cardinal Health: “I Can See That Stock Going to $300”

Oh, Jason Hollar. You cognize it’s funny… I’m retired there. You got each these large cause companies, and who americium I astir blown distant with? Hollar and Cardinal Health, and that urology purchase, the caller acquisition it conscionable made. You’re dormant right. CAH, I tin spot that banal going to $300.

Photo by Yiorgos Ntrahas connected Unsplash

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty cause services. The institution besides makes and distributes aesculapian and surgical products and process kits. During the January 8 episode, Cramer called the institution the “monster” among the cause distributors, arsenic helium commented:

The cause distributors proceed to relentlessly ascent higher. There’s nothing, you know, radical hatred the pharma middleman. Even the president doesn’t talk, like… them. But I got to archer you, their stocks, they are juggernauts. Cardinal Health, Cencora, and McKesson, they were each up much than 40% past year. Cardinal is truly the monster of that group.

While we admit the imaginable of CAH arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the champion short-term AI stock.

READ NEXT: 30 Stocks That Should Double successful 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This nonfiction is primitively published astatine Insider Monkey.